» Articles » PMID: 32876305

DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE

Abstract

Objective: To describe the case of an infant - diagnosed with incomplete Kawasaki disease - who developed BCG scar reactivation.

Case Description: A 6-month-old patient was admitted to hospital with fever associated with ocular hyperemia, cervical lymphadenopathy, and hyperemic lips, and remained hospitalized for 12 days. The physical examination revealed an inflammatory reaction at the site of the BCG scar, leading to the diagnosis of incomplete Kawasaki disease. The patient was treated with venous immunoglobulin, but presented recurrence of Kawasaki disease, with subsequent onset of coronary artery disease.

Comments: BCG scar reactivation is an important finding in countries where the vaccine is routinely given and may be a useful marker for early diagnosis of Kawasaki disease, especially in its incomplete form.

Citing Articles

BCG Scar Local Skin Inflammation as a Novel Reaction Following mRNA COVID-19 Vaccines in Two International Healthcare Workers.

Lopatynsky-Reyes E, Acosta-Lazo H, Ulloa-Gutierrez R, Avila-Aguero M, Chacon-Cruz E Cureus. 2021; 13(4):e14453.

PMID: 33996313 PMC: 8117721. DOI: 10.7759/cureus.14453.

References
1.
Uda K, Hataya H . Ulceration at Bacillus Calmette-Guérin Inoculation Site in a Patient with Kawasaki Disease. J Pediatr. 2015; 167(5):1167-7.e1. DOI: 10.1016/j.jpeds.2015.08.018. View

2.
Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H . Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr Infect Dis J. 2009; 29(5):430-3. DOI: 10.1097/INF.0b013e3181cacede. View

3.
Rezai M, Shahmohammadi S . Erythema at BCG Inoculation Site in Kawasaki Disease Patients. Mater Sociomed. 2014; 26(4):256-60. PMC: 4214810. DOI: 10.5455/msm.2014.26.256-260. View

4.
Seo J, Yu J, Ko H, Choi H, Kim Y, Ko J . Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site. Korean Circ J. 2013; 42(12):823-9. PMC: 3539048. DOI: 10.4070/kcj.2012.42.12.823. View

5.
McCrindle B, Rowley A, Newburger J, Burns J, Bolger A, Gewitz M . Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017; 135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484. View